ResearcherNational Cancer Center Research InstituteNo recent work listed

Kosei Nakajima

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4352-7817; OpenAlex author ID A5064145559. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 8

Papers, trials and grants by year

2022: 1 paper

Papers 1

Neoadjuvant therapy alters the collagen architecture of pancreatic cancer tissue via Ephrin-A5. Co-author DOI 10.1038/s41416-021-01639-9 ↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Noriteru Doi · 1 shared paper, 2022 · strength 0.14
- Paper Neoadjuvant therapy alters the collagen architecture of pancreatic cancer tissue via Ephrin-A5. DOI 10.1038/s41416-021-01639-9 ↗
Yoshinori Ino · 1 shared paper, 2022 · strength 0.14
- Paper Neoadjuvant therapy alters the collagen architecture of pancreatic cancer tissue via Ephrin-A5. DOI 10.1038/s41416-021-01639-9 ↗
Utako Ishimoto · 1 shared paper, 2022 · strength 0.14
- Paper Neoadjuvant therapy alters the collagen architecture of pancreatic cancer tissue via Ephrin-A5. DOI 10.1038/s41416-021-01639-9 ↗
Yoji Kishi · 1 shared paper, 2022 · strength 0.14
- Paper Neoadjuvant therapy alters the collagen architecture of pancreatic cancer tissue via Ephrin-A5. DOI 10.1038/s41416-021-01639-9 ↗
Kazuaki Shimada · 1 shared paper, 2022 · strength 0.14
- Paper Neoadjuvant therapy alters the collagen architecture of pancreatic cancer tissue via Ephrin-A5. DOI 10.1038/s41416-021-01639-9 ↗
Satoshi Nara · 1 shared paper, 2022 · strength 0.14
- Paper Neoadjuvant therapy alters the collagen architecture of pancreatic cancer tissue via Ephrin-A5. DOI 10.1038/s41416-021-01639-9 ↗
Nobuyoshi Hiraoka · 1 shared paper, 2022 · strength 0.14
- Paper Neoadjuvant therapy alters the collagen architecture of pancreatic cancer tissue via Ephrin-A5. DOI 10.1038/s41416-021-01639-9 ↗
Minoru Esaki · 1 shared paper, 2022 · strength 0.14
- Paper Neoadjuvant therapy alters the collagen architecture of pancreatic cancer tissue via Ephrin-A5. DOI 10.1038/s41416-021-01639-9 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.